KUALA LUMPUR: Duopharma Biotech Bhd
's growth strategy will be anchored by its market expansion plans including widening the presence and enhance the value of its halal-certified healthcare solutions on the international markets.
The pharma company expects to continue facing persistent challenges such as high electricity tariffs, elevated interest rates, and inflationary pressures; all of which is anticipated to exert pressure on manufacturing margins and overall profitability.
